Associated Papers
Cancer genomic profiling identified dihydropyrimidine dehydrogenase deficiency in bladder cancer promotes sensitivity to gemcitabine.
Tsukahara S et al.
Scientific Reports, 2022
35595780 (PubMed )
Supplement: 41598_2022_12528_MOESM2_ESM.pdf
Select a paper to view details